Altimmune Inc - ESG Rating & Company Profile powered by AI
This webpage is a zero-cost Environmental, Social and Governance analysis for Altimmune Inc. This analysis of Altimmune Inc incorporates data from across the internet as well as from available documents by Altimmune Inc. If you work at Altimmune Inc and you wish to use your Sustainability rating, please get in touch.
Altimmune Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.8.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Altimmune Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Altimmune Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Altimmune Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Altimmune Inc report the average age of the workforce?
Sign up for free to unlockDoes Altimmune Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Altimmune Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Altimmune Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Altimmune Inc offer flexible work?
Sign up for free to unlockDoes Altimmune Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Altimmune Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Altimmune Inc conduct supply chain audits?
Sign up for free to unlockDoes Altimmune Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Altimmune Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Altimmune Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Altimmune Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Altimmune Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Altimmune Inc disclose water use targets?
Sign up for free to unlockDoes Altimmune Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Altimmune Inc have a product recall in the last two years?
Sign up for free to unlockDoes Altimmune Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Altimmune Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Altimmune Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Altimmune Inc disclose parental leave metrics?
Sign up for free to unlockDoes Altimmune Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Altimmune Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Altimmune Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Altimmune Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Altimmune Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Altimmune Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Altimmune Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Altimmune Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Altimmune Inc disclose its waste policy?
Sign up for free to unlockDoes Altimmune Inc report according to TCFD requirements?
Sign up for free to unlockDoes Altimmune Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Altimmune Inc disclose energy use targets?
Sign up for free to unlockDoes Altimmune Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Altimmune Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Altimmune Inc
These potential risks are based on the size, segment and geographies of the company.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.